30 May2024Vesper Bio Announces Completion of Single Ascending Dose Stage In Trial of Its Lead Candidate VES001, A Potentially Disease-Modifying Treatment For Fronto-Temporal DementiaAuthor By Healthufit Posted on May 30, 2024May 30, 2024Vesper Bio Announces Completion of Single Ascending Dose Stage In Trial of...